Spots Global Cancer Trial Database for Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Official Title: Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma: a Prospective Umbrella Clinical Study
Study ID: NCT06255210
Conditions
Study Description
Brief Summary: The goal of this clinical trial is to learn about the induction chemotherapy efficacy in olfactory neuroblastoma. The main question it aims to answer is: wether olfactory neuroblastoma patients with different pathology subtypes apply to different induction chemotherapy schemes. Participants will be treated with different chemotherapy schemes, to evaluate the tumor remission rate and long term survival.
Detailed Description: This study included patients with olfactory neuroblastoma who were pathologically diagnosed and met the criteria. According to molecular profiles, two different induction chemotherapy schemes were used to evaluate the tumor remission rate.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Eye & ENT Hospital of Fudan University, Shanghai, Shanghai, China
Contact Details
Name: Hongmeng Yu, Prof.
Affiliation: Eye & ENT Hospital, Fudan University
Role: PRINCIPAL_INVESTIGATOR
Name: Xicai Sun, MD
Affiliation: Eye & ENT Hospital, Fudan University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
